During the past decade, The Asthma Institute, PLLC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "The Asthma Institute, PLLC" are "Asthma" (1 trials), "Atopic Dermatitis" (1 trials), "Chronic Sinusitis" (1 trials) and "Type I Hypersensitivity" (1 trials). Many other conditions were trialed in "The Asthma Institute, PLLC" in a lesser frequency.

Most popular intervention types in "The Asthma Institute, PLLC" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Levalbuterol" (1 trials), "Levalbuterol UDV TID" (1 trials), "Placebo" (1 trials), "Ragweed MATA MPL" (1 trials) and "SinuNase" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Asthma Institute, PLLC" are 4 trials for "All" genders.

Currently, there are NaN active trials in "The Asthma Institute, PLLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in The Asthma Institute, PLLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Asthma Institute, PLLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".